Amneal rolls out generic Felbamate suspension
Amneal Pharmaceuticals has launched what it said is the first generic Felbamate oral suspension in 600 mg/5 ml strength. Amneal said Wednesday that the first-to-market product is an AB-rated, therapeutically equivalent alternative to Meda Pharmaceuticals’ Felbatol.